Tanner Pharma Group Signs a Distribution Agreement for Partner Therapeutics’ Product, Leukine®


CHARLOTTE, N.C., May 24, 2018 08:00 AM 

(BUSINESS WIRE)– Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc. (PTx), an integrated biopharmaceutical company. The agreement names Tanner Pharma Group as a distributor of Leukine® (sargramostim) in areas outside of the United States and Canada where the product is not yet registered. Leukine® (sargramostim) is used to help increase ...

Continue Reading →